You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for benzyl alcohol


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for benzyl alcohol

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Get Started Free HaDH@@RVU[j@@@@ ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 485128_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 499226_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 514764_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 515663_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 515671_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 547514_ALDRICH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Benzyl Alcohol

Last updated: August 5, 2025

Introduction

Benzyl alcohol, a widely used preservative and solvent in the pharmaceutical industry, is a crucial active pharmaceutical ingredient (API) with applications spanning antiseptics, topical anesthetics, and as a stabilizer in various formulations. The integrity and purity of benzyl alcohol significantly influence the safety, efficacy, and regulatory approval of pharmaceutical products. As demand surges amid expanding pharmaceutical markets, identifying reliable, high-quality sources of bulk benzyl alcohol becomes paramount for manufacturers. This report provides an in-depth analysis of global API suppliers specializing in benzyl alcohol, assessing their manufacturing capabilities, quality standards, compliance, and market position.

Manufacturing Processes and Quality Standards

Benzyl alcohol is primarily synthesized via two principal routes:

  • Hydrogenation of Benzaldehyde: This catalytic process involves the hydrogenation of benzaldehyde, often derived from benzene, yielding benzyl alcohol. This method ensures high purity and minimal impurities, aligning with pharmaceutical-grade requirements.

  • Hydrolysis of Benzyl Chloride: This approach involves hydrolyzing benzyl chloride, which can be sourced from toluene derivatives. However, residual chlorides and other impurities must be tightly controlled to meet pharmaceutical standards.

Most reputable suppliers employ state-of-the-art production techniques adhering to Good Manufacturing Practices (GMP) and ISO standards to ensure product consistency and safety. The final API must conform to pharmacopoeial standards, such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), or Japanese Pharmacopoeia (JP), typically requiring a purity level of ≥99.8% and residual impurities below prescribed limits.

Key Global API Suppliers of Benzyl Alcohol

1. BASF SE

Overview:
BASF, a German multinational, is one of the world's leading chemical manufacturers with a significant portfolio in pharmaceutical excipients and APIs. Their benzyl alcohol is produced under strict quality control, ensuring pharmaceutical-grade standards (USP, EP compliant).

Manufacturing Capabilities:

  • Integrated production facilities in Europe and North America.
  • Advanced purification methods, including distillation and chromatography.
  • Consistent supply chain management.

Market Position:
BASF’s reputation for quality and innovation makes it a preferred supplier for large pharmaceutical firms seeking reliable and regulatory-compliant benzyl alcohol.

2. Sigma-Aldrich (Merck Group)

Overview:
Sigma-Aldrich, part of Merck KGaA, offers pharmaceutical-grade benzyl alcohol in bulk quantities. Their products are widely used in laboratory and manufacturing settings, adhering to rigorous quality standards.

Quality and Compliance:

  • Extensive documentation including Certificates of Analysis (CoA).
  • Meets USP, EP, and JP specifications.
  • Available in a variety of grades suitable for pharmaceutical applications.

Distribution Network:
Global reach with manufacturing and distribution centers across North America, Europe, and Asia.

3. Avantor (VWR International)

Overview:
Avantor supplies benzyl alcohol primarily for laboratory and pharmaceutical industries, emphasizing quality and regulatory compliance.

Production and Quality Control:

  • Sourced from leading chemical producers with ISO and GMP certifications.
  • Provides detailed QC data, ensuring consistency with pharmacopeial standards.

Market Focus:
Targets pharmaceutical R&D and scale-up manufacturing, offering customized packaging and regulatory support.

4. Jiangsu Haimo Pharmaceutical Co., Ltd. (China)

Overview:
A prominent Chinese API manufacturer with extensive benzyl alcohol production capacity serving international markets.

Regulatory Compliance:

  • GMP-certified facility compliant with international standards.
  • Offers products meeting USP, EP, and Chinese pharmacopeias.

Strengths:
Cost-effective sourcing with increasing integration into global supply chains. Stringent quality control measures enhance product reliability.

5. Toshima Chemical Industry Co., Ltd. (Japan)

Overview:
Specialized in specialty chemicals, Toshima produces high-purity benzyl alcohol suitable for pharmaceutical use.

Quality Assurance:

  • Adheres to strict Japanese pharmacopoeia standards.
  • Offers unique formulations with low impurity profiles.
  • Focuses on R&D collaborations.

Market Position:
Preferred for high-end formulations requiring superior purity.

6. TCI Chemicals (Tokyo Chemical Industries)

Overview:
A global chemical supplier with a dedicated portfolio for pharmaceuticals.

Product Attributes:

  • Pharmaceutical-grade benzyl alcohol available in bulk.
  • Ensures rigorous quality testing and documentation.

Distribution:
Global distribution channels with a focus on Asia-Pacific and North America.

7. Sancai Industry (China)

Overview:
Emerging Chinese supplier specializing in benzyl alcohol with competitive pricing and scaling capacity.

Quality & Certification:

  • Meets international standards including USP and EP.
  • GMP-compliant production processes.

Market Strategy:
Focuses on cost-efficient supplies for industry players prioritizing affordability.

8. UIP Group (United International Pharma)

Overview:
Indian manufacturer offering bulk benzyl alcohol with certifications aligned with international standards.

Regulatory Approach:
Integrated GMP practices, facilitating export to regulated markets.

Considerations for Source Selection

When selecting a benzyl alcohol supplier, pharmaceutical companies should evaluate:

  • Quality Certifications: GMP, ISO, and pharmacopeial compliance are non-negotiable.
  • Purity Profile: API must meet ≥99.8% purity with minimal residual impurities.
  • Regulatory Documentation: Certificates of analysis, safety data sheets, and stability data.
  • Supply Sustainability: Reliable production capacity and business continuity strategies.
  • Price Competitiveness: Balancing cost with quality and regulatory compliance.
  • Traceability: Ability to provide comprehensive batch records and history.

Regulatory and Supply Chain Trends

The global regulatory landscape increasingly emphasizes quality control, traceability, and environmental sustainability. Suppliers meeting International Council for Harmonisation (ICH) guidelines and adhering to ISO 9001 and GMP standards are favored. Additionally, geopolitical considerations, such as China’s rising production capacity and India’s expanding API sector, influence sourcing strategies. Pharmaceutical firms often diversify suppliers to mitigate risks associated with supply chain disruptions, especially under the evolving landscape post-pandemic.

Emerging Markets and Future Outlook

Emerging markets in Southeast Asia and Latin America are strengthening their API manufacturing sectors, driven by cost advantages and regional demand growth. However, ensuring compliance with stringent regulatory standards remains critical. As pharmaceutical companies pursue supply chain resilience, a composite sourcing model that combines established Western manufacturers with trusted regional suppliers gains prominence.

Key Takeaways

  • Regulatory compliance and high purity standards are essential, narrowing potential API sources to GMP-certified manufacturers.
  • Major global players include BASF, Sigma-Aldrich, and Avantor, known for consistent quality and supply reliability.
  • Chinese and Indian suppliers are growing, offering cost advantages but requiring rigorous validation of quality assurance.
  • Supply chain diversification helps mitigate risks amid geopolitical uncertainties and pandemic-induced disruptions.
  • Thorough qualification processes, including audits and QC reviews, are critical for establishing trusted supplier relationships.

FAQs

1. What are the key quality standards for pharmaceutical-grade benzyl alcohol?
Pharmaceutical-grade benzyl alcohol must meet pharmacopeial standards such as USP, EP, or JP, typically requiring ≥99.8% purity, minimal residual impurities, and compliance with GMP regulations.

2. Which regions dominate global benzyl alcohol production?
Europe and North America host most high-quality manufacturing facilities, with significant contributions from China and India due to cost advantages and expanding capacity.

3. How do I verify a supplier’s regulatory compliance?
Request Certificates of Analysis, GMP certificates, and independent audit reports. Additionally, verify their adherence to international standards through third-party inspections.

4. Are Chinese or Indian benzyl alcohol suppliers as reliable as Western manufacturers?
Many Chinese and Indian manufacturers comply with international standards and hold GMP certifications. Due diligence and supplier audits are critical to ensuring quality and regulatory compliance.

5. What are the emerging trends affecting benzyl alcohol sourcing?
Increasing regulatory scrutiny, supply chain diversification, environmental sustainability policies, and technological advancements in synthesis are shaping sourcing strategies.


References

  1. USP Monographs and Pharmacopoeia Standards. United States Pharmacopeia. 2022.
  2. European Pharmacopoeia (EP). European Directorate for the Quality of Medicines & HealthCare. 2023.
  3. Japanese Pharmacopoeia (JP). Ministry of Health, Labour and Welfare, Japan. 2022.
  4. Market reports on API manufacturing from Pharmaceutical Technology and ICIS.
  5. Industry certifications and supplier disclosures from company websites and documentation.

Disclaimer: This analysis is for informational purposes only. Buyers should perform independent due diligence and consult compliance experts before engaging suppliers.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.